Electromyography Diagnosis and Treatment with Botulin Toxin for Hemi facial Post Paralytic Spasm, Case Report
Carrillo Rivera Jorge Arnulfo1*,Ferraez Castañeda Carolina2,Daniel Flores Rodríguez3,Aguirre Solorio Berenice4,Tolentino Gonzalez Christian Stefan5,Juaréz Manrique Jesus6,Hector Jovany Inzunza7,García Luis Diana8,Medina Andrade Luis Angel9, Vallejo Ramirez José Eduardo10,Garcia Barajas Guillermo Antonio11
Copyright :© 2017 Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Electromyography is the study of muscle activity and their motor units, to diagnose the changes in electrical transmission and assess the changes after treatment.Postparalytic Hemifacial spasm is an involuntary hyperkinetic movement disorder that affects the muscles as a sequel of facial paralysis.Botulinum toxin is a derivative of Clostridium Botulinum microorganism that reduces muscle contraction by acetylcholine release blockade in the presynaptic motor nerve terminal.The aim of the present article is to know the electromyography activity of postparalytic hemifacial spasm in a patient after application of botulinum toxin.
1. Introduction
2. Case Report
At physical exam she presented postparalytic hemifacial spasm in right superciliary, nasogenian and chin region.
Initial electromyography showed a right facial nerve neuropathy with axonal degeneration grade III of House-Beckmann, a Botman and Jongkess moderated and Smith II paresis, with limitation of movements in frontal, orbicular and lip depressor muscles, with right temporal, zygomatic, buccal and marginal mandibular branches (Figure 1).
Electromyography signals detected in the left face muscles at rest (healthy side) were of 5 mV with a frequency of 10 Hz, but in the right face muscles (affected side) signals have a higher frequency of 40 Hz, with increased spontaneous activity of motor units by the involuntary contraction of muscular fibers every 3 to 5 milliseconds (Figure 2).
The conclusion of this study was a higher involuntary contraction force (vertical wave amplitude) in the lips depressor and frontal muscles, a higher frequency between spasm in the orbicularis muscle eyelids and lips, and lasting contraction in the upper lip lift muscle (Figure 3, 4 y 5).
With the electromyography reported results type A botulin toxin XeomeenMR was applied, 4 IU in the eyelid orbicular muscle, 6 IU in the lip depressor muscle and chip, and 8 IU in the frontal and upper lip lift.
During follow up at 15 daysthe control electromyography reports a fewer presence of involuntary movements in the affected muscles with an amplitude of 15Hz. The frequency improves significantly with a segment between spasm of more than 3 minutes. Although some abnormal characteristics in the driving unit were observed, the excitability of the muscle membrane improves, showing wide segments in the baseline.
3. Discussion
The ophthalmologic and neurologic exams are essential to stablish a diagnosis of essential benign spasm or secondary to systemic diseases like in Parkinson disease [5].
The post paralytic hemifacial spasm is secondary to an aberrant regeneration of new axons of the facial nerve to the facial muscle fibers.
This aberrant innervation produces a non-intentional movement in another area of the face. For example, when smiling the involuntary eyelid closure may be present [6].
The peripheralneurectomy of facial nerve is considered the more efficient treatment, other mentioned treatments are the alcohol infiltration to produce a chemical necrosis, percutaneous thermolysis or selective avulsion of facial nerve, with the severe secondary adverse effects [7,8].
Brin and Cols. mention a series of cases for the treatment of hemifacial spasm by the infiltration of botulin toxin, describing an improvement in 93.1% of periocular and perioral spasms, with an effect for 17.4 weeks [9,10].
The actual treatment for hemifacial spasm includes an electromyography to measure the motor unit activation and the electric variation after infiltration of botulin toxin. Botulinum toxin type A was introduced by Dr. Allen Scott in the late 60`s, being a derived obtained from Clostridium botulinum. The action mechanism is the blockade of acetylcholine release from the presynaptic motor nerve unit [4].
The contraindications for application of Botulin toxin are rare because is a drug classified as C category and their use is contraindicated during pregnancy, breastfeeding and neuromuscular diseases as myasthenia gravis, Eaton-Lambert syndrome and lateral amyotrophic sclerosis. This drug must be administered carefully in patients with consume of aminoglycosides,tetracycline, polymyxins, penicillin, anticholinesterases, and calcium channel blockers, because this may alter the conduction in the neuromuscular union [4,5,9].
According to other studies, the electromyography is very useful to identify the correct place and dose of botulin toxin administered, allowing us to control and follow up the involuntary muscular activity in a practical and safe way [8,10-12].
4. Conclusion
References